Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20207579 | 0.83 | — | — | |
| SCHEMBL17706896 | 0.83 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL12923477 | 0.77 | — | — | |
| SCHEMBL7202554 | 0.77 | — | — | |
| SCHEMBL3138572 | 0.73 | — | — | |
| SCHEMBL1419812 | 0.73 | SLC7A5 (0.41) | MEN1KMT2A | |
| SCHEMBL1419809 | 0.73 | SLC7A5 (0.41) | MEN1KMT2A | |
| SCHEMBL4911406 | 0.72 | — | — | |
| SCHEMBL2108621 | 0.71 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL7121206 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110313017-A1 | SNALP FORMULATIONS CONTAINING POLYOXAZOLINE-DIALKYLOXYPROPYL CONJUGATES | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313017-A1 | SNALP FORMULATIONS CONTAINING POLYOXAZOLINE-DIALKYLOXYPROPYL CONJUGATES | DAZAP1, SPOP, PNKP | MEN1 3196/4885KMT2A 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.